简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

12 Health Care Stocks Moving In Thursday's Pre-Market Session

2025-10-09 20:07

Gainers

  • Bluejay Diagnostics (NASDAQ:BJDX) shares rose 113.4% to $3.99 during Thursday's pre-market session. The market value of their outstanding shares is at $2.7 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock increased by 27.83% to $4.73. The market value of their outstanding shares is at $6.0 million.
  • Telomir Pharmaceuticals (NASDAQ:TELO) stock rose 26.63% to $2.09. The market value of their outstanding shares is at $53.2 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 21.53% to $9.37. The company's market cap stands at $4.7 million.
  • Akero Therapeutics (NASDAQ:AKRO) shares rose 17.68% to $54.71. The market value of their outstanding shares is at $3.7 billion.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) shares rose 16.1% to $0.24. The market value of their outstanding shares is at $55.7 million.

Losers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock decreased by 35.3% to $6.12 during Thursday's pre-market session. The market value of their outstanding shares is at $144.0 million.
  • AlphaTON Capital (NASDAQ:ATON) shares decreased by 25.03% to $8.18. The market value of their outstanding shares is at $65.7 million.
  • Processa Pharmaceuticals (NASDAQ:PCSA) shares decreased by 21.97% to $0.37. The company's market cap stands at $24.1 million.
  • Nexalin Technology (NASDAQ:NXL) shares decreased by 18.28% to $1.52. The company's market cap stands at $32.3 million.
  • GT Biopharma (NASDAQ:GTBP) shares decreased by 17.6% to $0.89. The company's market cap stands at $3.8 million.
  • Psyence Biomedical (NASDAQ:PBM) shares fell 17.57% to $3.66. The market value of their outstanding shares is at $1.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。